HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

tucotuzumab celmoleukin

consists of two interleukin-2 molecules fusion to a monoclonal antibody directed against EpCAM
Also Known As:
EMD 273066; EMD-273066; EMD273066; huKS-IL2
Networked: 6 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Gillies, Stephen D: 4 articles (12/2011 - 05/2004)
2. Connor, Joseph P: 2 articles (01/2013 - 05/2004)
3. Felder, Mildred: 2 articles (01/2013 - 05/2004)
4. Harter, Josephine: 2 articles (01/2013 - 05/2004)
5. Buhtoiarov, Ilia N: 2 articles (12/2011 - 08/2009)
6. Sondel, Paul M: 2 articles (12/2011 - 08/2009)
7. Lewis, Lionel D: 1 article (01/2013)
8. Stewart, Sarah: 1 article (01/2013)
9. Lewis, Nancy L: 1 article (01/2013)
10. Komarnitsky, Philip B: 1 article (01/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Prostatic Neoplasms (Prostate Cancer)
3. Adenocarcinoma
4. Ovarian Neoplasms (Ovarian Cancer)
5. Ascites

Related Drugs and Biologics

1. Interleukin-2 (IL2)
2. Cyclophosphamide (Cytoxan)
3. tumor-associated antigen GA733
4. Cytotoxins
5. tucotuzumab celmoleukin
6. Paclitaxel (Taxol)
7. Interleukin-2 Receptors (IL 2 Receptor)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Aftercare (After-Treatment)